Objective: Dysregulation of γ-aminobutyric acidergic (GABAergic) transmission has been reported in lesional acquired epilepsies (gliomas, hippocampal sclerosis). We investigated its involvement in a developmental disorder, human focal cortical dysplasia (FCD), focusing on chloride regulation driving GABAergic signals. Methods: In vitro recordings of 47 human cortical acute slices from 11 pediatric patients who received operations for FCD were performed on multielectrode arrays. GABAergic receptors and chloride regulators were pharmacologically modulated. Immunostaining for chloride cotransporter KCC2 and interneurons were performed on recorded slices to correlate electrophysiology and expression patterns. Results: FCD slices retain intrinsic epileptogenicity. Thirty-six of 47 slices displayed spontaneous interictal discharges, along with a pattern specific to the histological subtypes. Ictal discharges were induced in proepileptic conditions in 6 of 8 slices in the areas generating spontaneous interictal discharges, with a transition to seizure involving the emergence of preictal discharges. Interictal discharges were sustained by GABAergic signaling, as a GABA A receptor blocker stopped them in 2 of 3 slices. Blockade of NKCC1 Cl − cotransporters further controlled interictal discharges in 9 of 12 cases, revealing a Cl − dysregulation affecting actions of GABA. Immunohistochemistry highlighted decreased expression and changes in KCC2 subcellular localization and a decrease in the number of GAD67-positive interneurons in regions generating interictal discharges. Interpretation: Altered chloride cotransporter expression and changes in interneuron density in FCD may lead to paradoxical depolarization of pyramidal cells. Spontaneous interictal discharges are consequently mediated by GABAergic signals, and targeting chloride regulation in neurons may be considered for the development of new antiepileptic drugs. ANN NEUROL 2019;85:204-217 
genesis of epileptic activities, nor does it incriminate a subtype of abnormal cell, a neuronal network, or a causal molecular defect. Moreover, the onset site of the epileptic discharges remains to be assessed within the histological defect or at its boundary with the surrounding cortex. This is a key issue, because surgical resection, which is often the main therapeutic option, fails to cure about 40% of patients, mainly in type I FCD, presumably because of incomplete resection or because distant areas display high epileptogenicity in a complex epileptic network. [4] [5] [6] Mapping epileptic activities in various types of FCD is therefore mandatory to optimize the extent of their resection. Postsurgical FCD tissues thus offer a unique opportunity to study epileptogenicity mechanisms that should pave the way for new targeted therapies. Enhanced excitatory neurotransmission has been shown in dissociated neurons from human FCD. Increased Nmethyl-D-aspartate (NMDA) currents, reduced Mg 2+ sensitivity along with a decreased expression of the NR2B subunit, 7 and abnormal features of γ-aminobutyric acidergic (GABAergic) neurotransmission have also been involved in FCD's epileptogenicity. The number of inhibitory interneurons is globally reduced in type I-III FCD, and rearrangement of their cortical distribution is seen in type II FCD. [8] [9] [10] In the focal neonatal cortex freeze-lesion animal model of dysplasia, interneurons accumulate at the boundary of the lesion and ambient GABA is increased. 11 Moreover, in cortical slices from human postoperative FCD tissues, ictal-like events that are pharmacologically induced in vitro are abolished by hyperpolarizing interneurons or blocking GABAergic transmission. 12 In dissociated neurons from human FCDs, GABAergic currents of cytomegalic neurons exhibit immature features consisting of modified sensitivity to zolpidem and zinc and prolonged opening time 13 and display a pacemaker GABA A receptor-mediated activity. 14 However, as in other human epileptic conditions such as hippocampal sclerosis 15 or gliomas, 16 the shift to excitatory effects of GABAergic signals may contribute to FCD epileptogenicity. Previous studies have reported chloride cotransporter (sodium-potassium-chloride cotransporter 1 [NKCC1] and potassium-chloride cotransporter 2 [KCC2]) expression abnormalities in both the neonatal cortex freeze-lesion animal model of FCD and in human FCD. [17] [18] [19] This may result in increased neuronal chloride concentration and a shift toward depolarizing responses to GABA. 20 Other studies also showed that ictal discharges are initiated by interneurons and controlled by GABA A receptor blockade. However, these studies were not systematically performed at the network level and a precise mapping of epileptic activities within the malformations themselves was not performed to seek for local variability. They were specifically limited by the absence of spontaneous interictal discharges (IIDs), which in our work allowed assessment of epileptic areas. We here report that spontaneous IIDs can be recorded in vitro from acute cortical slices of human postoperative FCD. GABAergic signals positively participated to their genesis, as IIDs were blocked by GABA A receptor antagonists. This effect was related to perturbations of neuronal chloride regulation with a modification of KCC2 expression and an excess of activity of its counterpart NKCC1. NKCC1 blockade by bumetanide controlled epileptic discharges.
Patients and Methods
Patients' parents or legal guardians gave informed written consent according to the internal review board protocol (D2009-955 for storage of brain samples).
Patient Selection and Surgery
Cortical samples were obtained from 11 children with focal epilepsies and FCDs who underwent operations for drug-resistant epilepsy during a 2-year period. Seven other patients with FCD were not included in this study, as their cortex was not recorded in vitro, either because the parents refused to be enrolled in the study, or because of technical issues in the operating room or organizational mismatch between clinical and research teams.
Surgery was planned after multimodal preoperative evaluation including video-electroencephalographic (EEG) recording, neuropsychological examination, magnetic resonance imaging, and 18-fluorodeoxyglucose positron emission tomography. When required, intracranial chronic recording was performed according to stereo-EEG (SEEG) methodology. Antiepileptic drugs were maintained during the perioperative course. General anesthesia was induced with intravenous propofol injection and maintained by inhaled sevoflurane and intravenous sufentanil. Surgery was not modified for the research protocol and consisted of lobar or gyral en bloc resection, performed via a subpial technique, avoiding excessive specimen manipulation or coagulation, as intraoperative crush injury can cause loss of NeuN and other neuronal immunoreactivities. 21 Specimens were taken in the presumed ictal onset zone, defined either by SEEG, or by EEG and imaging (Fig 1) , and histological diagnosis was assessed according to International League Against Epilepsy (ILAE) recommendations. 22 A total of 11 pediatric patients were included in the study. Clinical data are summarized in the Table. Briefly, male/female ratio was 1.2, mean duration of epilepsy was 4.5 years (range = 0.7-13.9, SD = 4.2), age at surgery was 8 years (range = 0.9-16.9, SD = 4.6), and localization of the epileptogenic zone was frontal (n = 4), temporal (n = 4), or in the posterior quadrant (n = 3).
Histology was FCD type I (Ib, n = 1; Ic, n = 4), FCD type IIb (n = 3), and FCD type III (IIIA, n = 2; IIIb, n = 1).
Tissue Preparation
Cortical specimens were immediately placed in the operating room in iced sucrose-based artificial cerebrospinal fluid (ACSF) containing (in millimolars): 250 sucrose, 3 KCl, 25 NaHCO 3 , 10 D-Glucose, 1 CaCl 2 , 10 MgCl 2 , equilibrated with 5% CO 2 in 95% O 2 , and transported to the laboratory. 15, 23, 24 Meninges, blood clots, and vessels were gently removed, and 400 μm neocortical transverse slices were cut with a vibratome (HM650V; Microm Microtech, Brignais, France). Slice were stored in an interface chamber (Brain Slice Chamber 2; Scientific Systems Design, Mississauga, ON, Canada) at 37 C and continuously perfused with ACSF containing (in millimolars): 124 NaCl, 3 KCl, 26 NaHCO 3 , 10 D-Glucose, 1.6 CaCl 2 , 1.3 MgCl 2 , oxygenated with carbogen (5% CO 2 in 95% O 2 ), at 2 ml/min for at least 1 hour.
Microelectrode Array Recordings
A total of 47 slices were studied. Twenty-nine cortical slices were placed on planar microelectrode array (MEA) petri 25 We included in this study only the slices generating spontaneous IIDs.
All the recordings were performed in dysplastic cortex; in FCD III, we did not include peritumoral cortex (ganglioglioma) or hippocampal sclerosis that was located on the mesial part of the temporal lobe.
Histology
After MEA recordings, slices were fixed in 4% Zn formalin (Microm Microtech) for 24 hours. After intense phosphate-buffered saline (PBS) 1× wash, sections were permeabilized and blocked in PBS with 0.3% Triton X-100 and 5% normal goat serum (NGS) for 1 hour at room temperature. Incubation with primary antibodies diluted in PBS with 5% NGS and 0.1% Triton X-100 was carried out at 4 C overnight using anti-NeuN (Bachem, 1:1,000; Millipore, Billerica, MA), anti-pan-KCC2 (homemade, Ludwig et al 26 ), and anti-GAD67 (Millipore, MAB5406). After rinsing 3 times in PBS, slices were incubated with the corresponding Alexa Fluorconjugated secondary antibodies diluted in PBS (1/500; Invitrogen, Carlsbad, CA) for 2 hours at room temperature and finally counterstained for 1 minute with Hoechst 33258 (10 μg/ml in PBS; Sigma-Aldrich, St Louis, MO). Sections were then mounted onto Superfrost Plus glass slides in Fluoromount G mounting medium. For each section, images were taken using a confocal microscope with ×10, ×20, or ×40 objectives. Expression of KCC2 and GAD67-PV (parvalbumin [PV]) was compared between zones generating IIDs and silent zones, as defined by in vitro MEA recordings. KCC2 expression was analyzed using single cell analysis under the Plot Profil Plugin in ImageJ, as described in Tyzio et al, 27 by plotting fluorescence intensity along the cell and comparing epileptic areas to silent areas identified by MEA recordings. Delimitation of epileptic and nonepileptic areas was done considering all layers of a square of 2,000 μm, corresponding to the area surrounding an MEA electrode.
Morphological analysis was performed after slicing the remaining tissue, and immunostaining with Nissl and NeuN. We did not study the white matter.
ILAE criteria were used for the classification of FCDs as follows. FCD I refers to radial (Ia), tangential (Ib), or mixed (Ic) dyslamination of the neocortex; FCD II is characterized by dysmorphic neurons without (IIa) or with balloon cells (IIb); and FCD III is defined by the association of dyslamination to a lesion. 3 
Electrophysiological Analysis and Statistics
Local field potentials (LFPs) were analyzed with Clampfit software (pClamp Software; Molecular Devices, Sunnyvale, CA), using visual analysis and the automated event detector toolbox via threshold detection. Statistical analysis was performed on SPSS Statistics software (IBM, Armonk, NY). Results were expressed as mean AE standard deviation, and significance level was set at p < 0.05. Intergroup analysis was done with nonparametric Kruskal-Wallis test, and Wilcoxon test was used for repeated measurement on a single sample.
Visual analysis of the LFP matrix under MC-Data software (Multi Channel Systems) was used to count the number of contacts displaying consistent IIDs. The area of cortex generating IIDs was then calculated by multiplying by the surface underneath each electrode (product of horizontal [1,500 μm] and vertical [1,000 μm] interelectrode distance = 1.5 mm 2 ). The depth of IID initiation was measured orthogonally to the tangent of the pial surface between the pia and the electrode contact showing either phase inversion or maximum amplitude. High-frequency oscillations (HFOs) were analyzed with Ripple Lab according to previously described methodology. 28 Briefly, after filtering (80-500 Hz) and timefrequency analysis with the wavelet transform, HFOs were either visually detected or automatically detected using Hilbert method. Duration and mean frequency of the HFO events were then noted for IIDs and preictal discharges (PIDs), respectively. Seizures were analyzed with Spike 2 software using time-frequency representation and classified according to the discharge frequency and pattern as oscillatory (<20 Hz) or low-voltage fast-activity (LVFA) events.
Results
Postoperative Tissues from Human FCD Retain Intrinsic Epileptic Activities In Vitro FCD Slices Generate Spontaneous IIDs. Forty-seven slices from 11 patients were studied on MEAs (median = 4 slices/patient). Spontaneous IIDs were recorded in 36 slices (76.5%) in physiological ACSF (Fig 2A) . IIDs were generated at a mean depth of 2 AE 1 mm from the pial surface, and the mean cortical surface displaying IIDs was 7.4 AE 2.9 mm 2 , corresponding to 8.9% of the cortical surface explored with MEA contacts (on the large 12 × 10 matrix). We observed a rhythmic pattern of IIDs, with a mean frequency of 1.59 AE 1.03 Hz (n = 3,678 events from 36 slices), a mean duration of 67.9 AE 70.8 milliseconds, and a mean amplitude of 23.8 AE 14.2 μV.
IID pattern varied according to the FCD histological type (see Fig 2B, C) When comparing patients who were < 5 years old (yo) to patients >5 yo, age was found to have a statistically significant effect on IID patterns (Mann-Whitney test, p < 0.01). IID occurrence was more frequent after 5 yo (1.8 AE 1 Hz) than before 5 yo (0.2 AE 0.4 Hz), with a larger amplitude at >5 yo (27.1 AE 12 μV) than <5 yo (13.9 AE 9.2 μV) and a shorter duration (55.5 AE 48.2 milliseconds) after 5 yo than before (125.2 AE 88 milliseconds). Fig 3A) . FCD type II was not studied in proepileptic conditions. The first seizure occurred after a mean delay of 1,057 seconds (range = 255-2,695, SD = 901, n = 6 slices) and was preceded by large-amplitude PIDs in 5 of 6 cases, as already described in human tissues such as the subiculum in cases of hippocampal sclerosis 26 or peritumoral neocortex. 16 Seizures then recurred with a mean interval of 84 seconds (range = 11.7-342, SD = 84.3). Mean seizure duration was 73.3 seconds (range = 25.3-206.3, SD = 38.4) and was not statistically different between the 3 histological subtypes (Kruskal-Wallis test, p = 0.583). Among the 40 seizures recorded, the discharge pattern was an LVFA event with a mean frequency of 134.4 Hz (range = 119-148, SD = 10.8) followed by rhythmic bursts in 15 cases, and an oscillatory pattern with direct rhythmic bursts (synchronous pattern) occurring at a frequency of 10.6 Hz (range = 2.7-25, SD = 8.4) in the remaining cases (n = 25; see Fig 3B) . The discharge pattern was stable over time, as in 84% of the slices, the first recorded seizure was followed by an identical type of discharge, regardless of the histological subtype. However, the seizure pattern evolved during the course of the recording in 3 of 6 slices displaying ictal discharges, the inaugural seizure representing the majority of the seizure pattern subtype during the recording in 3 of 6 cases. The seizure onset pattern was significantly different between FCD type I and FCD type III (chi-squared test, p = 0.008), as sharp activity was noted in 9 of 9 seizures in FCD type I as compared to 16 of 31 in type III.
In most cases, the area generating IIDs overlapped with regions generating ictal-like events (see Fig 3A) and the surface of the cortex displaying seizure activity increased as compared to IIDs on the large MEA (4 slices), from 6 AE 3.2 mm 2 to 15 AE 7.8 mm 2 . However, in 1 case (FCD III), ictal discharges emerged simultaneously in 2 distinct areas with the same electrophysiological pattern (distant by 4 mm); interestingly, 1 of the 2 areas had no previous IIDs. Epileptic Activities Correlate to Histological Defects. Histological analysis was done after MEA recording in 5 slices with sufficient specimen quality and quantity (FCD IIb, n = 2; FCD Ic, n = 1; FCD IIIa, n = 2). It confirmed that the areas generating IIDs were within the FCD and presented dyslamination (4 cases; see Fig 1D) or dysmorphic neurons (1 case). However, there was no obvious heterogeneity in terms of cellular or architectural abnormalities in slices, for instance when comparing areas generating IID to silent zones.
Epileptic IIDs Are Associated with Altered GABAergic Inhibition
GABAergic Neurotransmission Is Involved in IID Generation.
To test whether GABAergic signaling is positively involved in the production of epileptic activities in human dysplastic tissues, 12 we studied GABA A signaling in 3 slices from 3 patients (FCD type Ic, IIb, and IIIa) by applying the specific antagonist picrotoxin (100 μM). In 2 of the 3 slices, picrotoxin stopped IIDs after a delay of 90 and 1,001 seconds, respectively (Fig 4A) . In the third slice (FCD type Ic), IID frequency in picrotoxin (0.5 AE 0.27 Hz) was significantly (Mann-Whitney test, p < 0.001) lower than in physiological ACSF (0.9 AE 0.7 Hz).
To investigate an alteration in inhibitory networks, 10 we quantified the total number of interneurons within the cortical areas in 3 slices producing IIDs (FCD Ic, n = 2; FCD IIIa, n = 1) compared to zones devoid of epileptic activity in 4 slices. We compared the number of GAD67 cells in epileptic areas to nonepileptic areas, as detected by MEA recordings, considering all layers of a column of 2,000 μm, corresponding to the area surrounding an MEA electrode (see Fig 4B) . In epileptogenic areas, the total number of GAD67-positive cells (normalized mean = 0.53 AE 0.19) was significantly reduced (MannWhitney test, p = 0.0018) compared to the areas in which no epileptic discharge was recorded (normalized mean = 0.95 AE 0.43).
Chloride Cotransporter Abnormalities Support Epileptic
Activity Genesis. Low neuronal chloride concentration is maintained in mature neurons mainly by the expression of the Cl − extruder KCC2, together with the repression of the Cl − loader NKCC1. 30 We explored the activity of NKCC1 and the expression of KCC2 in dysplastic tissues with perturbed GABAergic signaling.
The effects of the specific blockade of the chloride cotransporter NKCC1 by the diuretic bumetanide was assessed in 12 slices from 7 patients. Bumetanide (8 μM) suppressed IIDs in 9 of 12 slices with a mean delay of 1,205 AE 670 seconds (Fig 5A) . IIDs reappeared after washout in physiological ACSF with a mean delay of 422 AE 290 seconds. In the remaining 3 cases, bumetanide had no effect in 1 case of FCD type Ic and was associated with a reduction of both frequency (2.06 AE 0.8 Hz vs 1.5 AE 0.8 Hz) and amplitude (21.8 AE 5.9 μV vs 20.1 AE 4.8 μV) in 2 cases of FCD type Ic (MannWhitney test, p < 0.001). These data show that presumed upregulated NKCC1 contributes to the production of IIDs. However, due to the lack of specific antibody, we were not able to study its expression by immunochemistry.
Considering both the intrinsic activity and the effect of bumetanide on slices, we then investigated the expression and the subcellular localization of KCC2 using single cell analysis by plotting fluorescence intensity along the cell and comparing epileptic areas to silent areas identified by MEA recordings (see Fig 5B) .
The analysis done after Gaussian fitting of the curve reveals a change in the fluorescence repartition, with a significant decrease of the membrane staining as confirmed by the quantitative analysis of the area under the curve (epileptic = 181.6 vs nonepileptic = 152.1; KolmogorovSmirnoff test, p < 0.001), supporting internalization and/or altered membrane trafficking of KCC2 (see Fig 5C) . These results were correlated with a quantitative analysis of the KCC2 immunoreactivity. For this, we focused on the number of neurons exhibiting an increased cytoplasmic fraction of KCC2. We quantified KCC2 staining in silent zones versus epileptic ones, and we observed a striking reduction of cells with KCC2 localized close to the membrane (65.8 AE 1.4% vs 10.46 AE 1.6%, p < 0.0001), together with an increase of the KCC2 fraction expressed in the cytoplasm (34.15 AE 1.4% vs 89.53 AE 1.6%, p < 0.0001).
Altogether, these immunostaining results show that KCC2 is internalized and thus less able to maintain low interneuronal chloride concentration, which is mandatory for it to exert its hyperpolarizing inhibitory effects. Together with the excess of functionality of NKCC1, we suggest that it leads to increased neuronal concentration of GABA and its depolarizing, eventually excitatory effects that are responsible for epileptic activities. This assumption is ascertained by the blocking effect of GABA A antagonists on epileptic activities.
Discussion
In this study, we show that slices from postoperative human pediatric dysplastic cortex retain epileptogenic properties at the network level, as they still generate spontaneous interictal epileptic discharges in vitro, in all 3 main types of dysplastic subtypes. We also observe that the electrophysiological pattern of IIDs depends on the subtype of FCD, although IIDs are spatially restricted to a portion of the slice in all FCD subtypes. We show that GABAergic signaling is actively involved in IID genesis. Putative depolarizing effects of GABA, released by interneurons that are decreased in number, are suggested to be related to a dysregulation of neuronal chloride with an excessive load by the cotransporter NKCC1 and a defective extrusion by its counterpart KCC2. Finally, we show that in proepileptic conditions, dysplastic tissues are able to generate ictal-like discharges, triggered by specific PIDs, with a high-frequency oscillation signature.
This study admits several limitations. The size of our cohort is small and based on variable FCD subtypes. Thus, larger studies are needed to confirm our findings. However, work on human FCD samples is limited by the number of surgical cases and collaborative studies are difficult, as these studies need to be performed on acute slices. MEA recordings were performed at the LFP level, and in acute slices, the distance between contacts and signal/noise ratio did not allow spike sorting and therefore did not allow categorization of the neuronal subgroups initiating IIDs. Moreover, no intracellular recordings allowed identification of the cellular subtypes involved in population discharges or measurement of the reversal potential of chloride-related GABAergic currents. Slicing the cortex has been demonstrated to alter the extracellular matrix and to modify the chloride reversal potential, 31 at least in superficial layers. However, in our past studies, spontaneous epileptic activities have never been recorded in vitro from control human tissue. 16, 25, 29 Furthermore, IIDs were found to be focal and generated at a similar site in consecutive slices from the same tissue, indicating that local preexisting modifications are involved in the response rather than direct traumatism related to the slicing procedure. The morphological histological analysis was performed on 8% of the samples, and therefore these results need to be carefully interpreted. This study provides further evidence regarding the epileptogenic mechanisms of FCD. Previous studies reported several possible mechanisms underlying the epileptogenicity in FCD. Glutamatergic transmission supports ictogenesis in human FCD slices, 32 due to an increased expression and altered composition of NMDA (NR2B subunit) receptors. 7, [33] [34] [35] Alteration of the extracellular matrix through increased expression of metalloproteinase 9 leading to putative modified intra-and extracellular chloride levels has been reported. 36 Involvement of purinergic transmission was also proposed, via an excess of adenosine triphosphate release through pannexin 1 channels, 37 although this pathway is not specific to FCD epileptogenesis. 25 Here, we focused specifically on GABAergic mechanisms. First, we show that FCDs display different IID patterns according to their histology. IID frequency was higher in types I and II than in type III, suggesting that the severity of cortical disorganization was correlated with the ability to generate IIDs. These electrophysiological findings differ from previous histological studies that segregated FCD types I and III from FCD type II. 10 In previous studies, immunostaining of PV interneurons showed a global reduction of PV immunoreactivity in type I and III FCDs, which was not significantly different from cryptogenic cases. In type II FCDs, the number of PV/GAD65/67 neurons did not appear to be modified, but their location was redistributed, 10 although other studies found a clear decrease in PV interneurons, especially in layer IV in FCD IIb cases, 38 and a global reduction in IIa and IIb cases. 39 Calretinin interneuron density is itself reduced in type I and II FCDs. 39, 40 Our data point to a global reduction of interneurons, but the amount of tissue we could study did not allow correlating these alterations with FCD subtypes. Correlation between clinical, imaging, electrocorticographic, histologic, and electrophysiological responses from dissociated neurons further suggested that in the most severe areas of FCD, glutamatergic activity is decreased, whereas GABAergic activity appears to be reinforced. 41 Second, GABA A receptor blockade suppressed IIDs in 2 of 3 cases, with limited effect in a type Ib FCD. Dysfunction of GABAergic transmission has already been demonstrated in acute human slices of FCD and on dissociated neurons. However, previous data have proposed that reduced inhibition contributed to FCD epileptogenicity or did not directly study the characteristics of GABAergic signaling in basal conditions. Whole-cell patch-clamp recordings from pyramidal cells in human FCD slices revealed reduced inhibitory postsynaptic current frequency, along with a decrease in GABA reuptake function. 8 Increased GABAergic currents were recorded in cytomegalic neurons along with a decreased sensitivity to zolpidem and zinc, thus indicating altered α1 and γ2 subunits of GABA receptor. 13 When bathed in the potassium channels blocker 4-AP, acute slices of FCD from epileptic patients can generate interictal and ictal discharges, but no activity has yet been reported in basal condition. 32 Blocking GABA A receptors transformed the ictal activity into regular interictal-like activity (eventually preictal), whereas increasing GABAergic transmission with phenobarbital increased the duration and amplitude of both ictal and interictal events. 12 Our study is the first showing spontaneous epileptic activities in vitro, stressing the epileptic nature of the studied tissue in the presence of eventually large histological defects. In addition, it shows the positive involvement of GABAergic transmission and demonstrates that spontaneous IIDs are triggered rather than controlled by GABA A signals. Such a pharmacological pattern suggests that IIDs may be initiated by interneurons, as already shown in vitro in human subiculum 15, 24, 29 and peritumoral cortex, 16 as well as in CA1 in vivo using Ca
2+
imaging network analysis in a mouse model of chronic temporal lobe epilepsy. 42 These data may partially explain the pharmacoresistance of FCD. Our results are also in agreement with interictal intracranial recordings of human patients, as intravenous injection of the GABA A agonist diazepam did not suppress continuous spiking inside the dysplastic cortex. 43 Third, the selective blockade of NKCC1 by bumetanide stopped IIDs generated in the dysplastic cortex. To our knowledge, this is the first report of the antiepileptic effect of bumetanide in human cortical slices of FCD. NKCC1 drives neuronal chloride influx, supports the depolarizing effect of GABA early in embryogenic life, and is later counterbalanced by KCC2 chloride cotransporter expression that leads to chloride hyperpolarizing currents at GABA A receptor activation.
20 NKCC1 expression itself has been shown to be increased in human dysplastic tissues, 18, 19, [44] [45] [46] especially in type IIb FCDs 19, 46 and within the dysplastic component. 45, 46 Immunostaining studies showed an increase in NKCC1 immunoreactivity (with the limitation of the specificity of the antibodies) in FCD IIb in both neurons (especially those expressing GABA A receptor subunit α1) and glial cells as compared to control cortex. 46 Our study confirms the functional implication of NKCC1 upregulation by showing that its blockade controls interictal activities. In contrast, if neuronal somatic KCC2 immunoreactivity was observed in 67% of the cases, their cellular distribution was altered. This was confirmed in both tuberous sclerosis complex and FCD IIb postoperative human tissues with an increase of the NKCC1/KCC2 ratio. 19 This shift in chloride cotransporter toward embryonic expression may also be worsened by the localization of KCC2 in FCD IIb, as immunoreactivity was found in the cytoplasm of cytomegalic neurons, but not on the membrane per se.
19
KCC2 downregulation seems to occur in normal-looking neurons within dysplasias, 18 suggesting that nondysplastic components may directly contribute to an impaired synaptic inhibitory function. Such KCC2 dysregulation may differ between FCD subtypes. 47 In FCD Ia and Ib, as well as in IIb type, KCC2 staining is diffuse in the neuropil (resembling a normal expression pattern) within the disorganized cortex, whereas somatic expression is reduced. Moreover, KCC2 staining seems to be increased in the cytoplasm only in type IIb. At a cellular level, KCC2 labeling is mainly intracytoplasmic in giant pyramidal and dysmorphic cells, whereas balloon cells do not seem to express the cotransporter at all. Animal models provide nonconclusive data, stressing the need to study human tissues. For example, in the methylazoxymethanol acetate rodent model of FCD, KCC2 expression is paradoxically increased, 48 whereas it is reduced in the neonatal cortex freeze-lesion animal model. 11, 49 Here, we confirm that KCC2 subcellular expression is altered, but whether increased internalization of the receptor or deficient membrane trafficking is responsible remains to be determined. Translation of these results to patient's pharmacology is premature, as previous clinical studies failed to demonstrate the antiepileptic effect of bumetanide in epileptic newborns with hypoxic encephalopathy despite basic science evidence. 50 However, development of new drugs targeting chloride cotransporters with higher blood-brain barrier permeability, longer half-life, and transporter specificity to increase their efficiency and decrease the side effects could be an adjunct to classical antiepileptic drugs in FCD.
Conclusion
In vitro recording of acute cortical slices from human FCD highlights the role of GABAergic transmission in the generation of spontaneous IIDs via a perturbed chloride homeostasis. Such a defect, shared with other epilepsies as hippocampal sclerosis and tumor-related epilepsy, suggests that GABAergic/chloride dysfunction may be a common mechanism, which could be considered as an alternative target for the development of new antiepileptic strategies.
